Search results
Results from the WOW.Com Content Network
The term leukemoid reaction describes an increased white blood cell count (> 50,000 cells/μL), which is a physiological response to stress or infection (as opposed to a primary blood malignancy, such as leukemia). It often describes the presence of immature cells such as myeloblasts or red blood cells with nuclei in the peripheral blood.
T-cell acute lymphoblastic leukemia (T-ALL) is a type of acute lymphoblastic leukemia characterized by an aggressive malignant neoplasm of the bone marrow. [6] Acute lymphoblastic leukemia (ALL) is a condition, wherein immature white blood cells accumulate in the bone marrow and crowd out normal white blood cells. [7]
The excessive immature lymphocytes in the bone marrow interfere with the production of new red blood cells, white blood cells, and platelets. [1] Diagnosis is typically based on blood tests and bone marrow examination. [3] Acute lymphoblastic leukemia is typically treated initially with chemotherapy aimed at bringing about remission. [2]
These blood cells are not fully developed and are called blasts or leukemia cells. [2] Symptoms may include bleeding and bruising, bone pain, fatigue, fever, and an increased risk of infections. [2] These symptoms occur due to a lack of normal blood cells. [2] Diagnosis is typically made by blood tests or bone marrow biopsy. [2]
The condition is characterized by abnormal aggregation and clumping of white blood cells in the blood vessels resulting in impaired blood flow and delivery of oxygen to the body's cells. The brain and lungs are the two most commonly affected organs. [6] Leukostasis most commonly occurs with acute myeloid leukemia.
BAALC is a gene that codes for the brain and acute leukemia cytoplasmic protein. [1] The official symbol (BAALC) and official name (brain and acute leukemia cytoplasmic) is maintained by the HGNC. [2] The function of BAALC is not fully understood yet, but has been suggested to have synaptic roles involving the post synaptic lipid raft. [3]
The T cell variations are usually caused by the prolonged use of T cell suppressant drugs, such as sirolimus, tacrolimus, or ciclosporin. [2] The Epstein-Barr virus , which infects >90% of the world population, is also a common cause of these disorders, being responsible for a wide range of non-malignant, pre-malignant, and malignant Epstein ...
Tumor lysis syndrome (TLS) is a group of metabolic abnormalities that can occur as a complication from the treatment of cancer, where large amounts of tumor cells are killed off from the treatment, releasing their contents into the bloodstream. [1]